{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:32:49Z","timestamp":1760401969158,"version":"build-2065373602"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19487-5","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:18:54Z","timestamp":1760361534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia"],"prefix":"10.1038","volume":"15","author":[{"given":"Shusuke","family":"Yazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Mochizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuki","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyogo","family":"Naoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Karayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Imokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Koshimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Yokomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Sumikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"19487_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1465-9921-14-86","volume":"14","author":"DS Kim","year":"2013","unstructured":"Kim, D. S. Acute exacerbations in patients with idiopathic pulmonary fibrosis. Respir Res. 14, 86. https:\/\/doi.org\/10.1186\/1465-9921-14-86 (2013).","journal-title":"Respir Res."},{"key":"19487_CR2","first-page":"103","volume":"27","author":"Y Kondoh","year":"2010","unstructured":"Kondoh, Y. et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 27, 103\u2013110 (2010).","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"19487_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1183\/09031936.00159709","volume":"37","author":"JW Song","year":"2011","unstructured":"Song, J. W., Hong, S. B., Lim, C. M., Koh, Y. & Kim, D. S. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur. Respir J. 37, 356\u2013363. https:\/\/doi.org\/10.1183\/09031936.00159709 (2011).","journal-title":"Eur. Respir J."},{"key":"19487_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.rmed.2008.12.019","volume":"103","author":"T Suda","year":"2009","unstructured":"Suda, T. et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med. 103, 846\u2013853. https:\/\/doi.org\/10.1016\/j.rmed.2008.12.019 (2009).","journal-title":"Respir Med."},{"key":"19487_CR5","doi-asserted-by":"publisher","first-page":"175346662093577","DOI":"10.1177\/1753466620935774","volume":"14","author":"N Enomoto","year":"2020","unstructured":"Enomoto, N. et al. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis. Ther. Adv. Respir Dis. 14, 1753466620935774. https:\/\/doi.org\/10.1177\/1753466620935774 (2020).","journal-title":"Ther. Adv. Respir Dis."},{"key":"19487_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000329893","volume":"83","author":"R Tachikawa","year":"2012","unstructured":"Tachikawa, R. et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 83, 20\u201327. https:\/\/doi.org\/10.1159\/000329893 (2012).","journal-title":"Respiration"},{"key":"19487_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1378\/chest.07-0323","volume":"132","author":"IN Park","year":"2007","unstructured":"Park, I. N. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132, 214\u2013220. https:\/\/doi.org\/10.1378\/chest.07-0323 (2007).","journal-title":"Chest"},{"key":"19487_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard, H. R. et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am. J. Respir Crit. Care Med. 194, 265\u2013275. https:\/\/doi.org\/10.1164\/rccm.201604-0801CI (2016).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"19487_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fmed.2017.00176","volume":"4","author":"G Leuschner","year":"2017","unstructured":"Leuschner, G. & Behr, J. Acute exacerbation in interstitial lung disease. Front. Med. (Lausanne). 4, 176. https:\/\/doi.org\/10.3389\/fmed.2017.00176 (2017).","journal-title":"Front. Med. (Lausanne)"},{"key":"19487_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1183\/09031936.06.00114004","volume":"27","author":"DS Kim","year":"2006","unstructured":"Kim, D. S. et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur. Respir J. 27, 143\u2013150. https:\/\/doi.org\/10.1183\/09031936.06.00114004 (2006).","journal-title":"Eur. Respir J."},{"key":"19487_CR11","doi-asserted-by":"publisher","unstructured":"Collard, H. R. et al. Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis. Eur. Respir J. 49 https:\/\/doi.org\/10.1183\/13993003.01339-2016 (2017).","DOI":"10.1183\/13993003.01339-2016"},{"key":"19487_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.resinv.2024.03.006","volume":"62","author":"N Enomoto","year":"2024","unstructured":"Enomoto, N. Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review. Respir Investig. 62, 465\u2013480. https:\/\/doi.org\/10.1016\/j.resinv.2024.03.006 (2024).","journal-title":"Respir Investig"},{"key":"19487_CR13","doi-asserted-by":"publisher","unstructured":"Enomoto, N. et al. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis. Chronic Resp. Dis. 16 https:\/\/doi.org\/10.1177\/1479972318809476 (2018).","DOI":"10.1177\/1479972318809476"},{"key":"19487_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer, A. et al. An official European respiratory society\/american thoracic society research statement: interstitial pneumonia with autoimmune features. Eur. Respir J. 46, 976\u2013987. https:\/\/doi.org\/10.1183\/13993003.00150-2015 (2015).","journal-title":"Eur. Respir J."},{"key":"19487_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/thoraxjnl-2020-216263","volume":"77","author":"N Enomoto","year":"2022","unstructured":"Enomoto, N. et al. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax 77, 143\u2013153. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216263 (2022).","journal-title":"Thorax"},{"key":"19487_CR16","doi-asserted-by":"publisher","first-page":"107577","DOI":"10.1016\/j.rmed.2024.107577","volume":"224","author":"N Enomoto","year":"2024","unstructured":"Enomoto, N. et al. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study. Respir Med. 224, 107577. https:\/\/doi.org\/10.1016\/j.rmed.2024.107577 (2024).","journal-title":"Respir Med."},{"key":"19487_CR17","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","volume":"47","author":"JM Oldham","year":"2016","unstructured":"Oldham, J. M. et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur. Respir J. 47, 1767\u20131775. https:\/\/doi.org\/10.1183\/13993003.01565-2015 (2016).","journal-title":"Eur. Respir J."},{"key":"19487_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","volume":"190","author":"M Natsuizaka","year":"2014","unstructured":"Natsuizaka, M. et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am. J. Respir Crit. Care Med. 190, 773\u2013779. https:\/\/doi.org\/10.1164\/rccm.201403-0566OC (2014).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"19487_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard, H. R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir Crit. Care Med. 176, 636\u2013643. https:\/\/doi.org\/10.1164\/rccm.200703-463PP (2007).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"19487_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.resinv.2014.08.003","volume":"53","author":"S Homma","year":"2015","unstructured":"Homma, S., Sugino, K. & Sakamoto, S. Usefulness of a disease severity staging classification system for IPF in japan: 20 years of experience from empirical evidence to randomized control trial enrollment. Respir Investig. 53, 7\u201312. https:\/\/doi.org\/10.1016\/j.resinv.2014.08.003 (2015).","journal-title":"Respir Investig"},{"key":"19487_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12890-022-02197-3","volume":"22","author":"N Enomoto","year":"2022","unstructured":"Enomoto, N. et al. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases. BMC Pulm Med. 22, 387. https:\/\/doi.org\/10.1186\/s12890-022-02197-3 (2022).","journal-title":"BMC Pulm Med."},{"key":"19487_CR22","doi-asserted-by":"publisher","first-page":"106898","DOI":"10.1016\/j.rmed.2022.106898","volume":"200","author":"J Otsuka","year":"2022","unstructured":"Otsuka, J. et al. Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: comparison with idiopathic pulmonary fibrosis. Respir Med. 200, 106898. https:\/\/doi.org\/10.1016\/j.rmed.2022.106898 (2022).","journal-title":"Respir Med."},{"key":"19487_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1183\/09031936.06.00038806","volume":"28","author":"T Suda","year":"2006","unstructured":"Suda, T. et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur. Respir J. 28, 1005\u20131012. https:\/\/doi.org\/10.1183\/09031936.06.00038806 (2006).","journal-title":"Eur. Respir J."},{"key":"19487_CR24","first-page":"58","volume":"32","author":"T Fujisawa","year":"2005","unstructured":"Fujisawa, T. et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J. Rhuematol. 32, 58\u201364 (2005).","journal-title":"J. Rhuematol."},{"key":"19487_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","volume":"18","author":"N Hayashi","year":"2008","unstructured":"Hayashi, N. et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod. Rheumatol. 18, 153\u2013160. https:\/\/doi.org\/10.3109\/s10165-008-0028-1 (2008).","journal-title":"Mod. Rheumatol."},{"key":"19487_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","volume":"78","author":"S Sabbagh","year":"2019","unstructured":"Sabbagh, S. et al. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann. Rheum. Dis. 78, 988\u2013995. https:\/\/doi.org\/10.1136\/annrheumdis-2018-215004 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"19487_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.42075","volume":"74","author":"EL Matteson","year":"2022","unstructured":"Matteson, E. L. et al. Nintedanib in patients with autoimmune Disease-Related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial. Arthritis Rheumatol. 74, 1039\u20131047. https:\/\/doi.org\/10.1002\/art.42075 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"19487_CR28","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"G Raghu","year":"2012","unstructured":"Raghu, G., Anstrom, K. J., King, T. E. Jr., Lasky, J. A. & Martinez, F. J. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl. J. Med. 366, 1968\u20131977. https:\/\/doi.org\/10.1056\/NEJMoa1113354 (2012).","journal-title":"N Engl. J. Med."},{"key":"19487_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir Crit. Care Med. 183, 788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL (2011).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"19487_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis, W. D. et al. An official American thoracic society\/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir Crit. Care Med. 188, 733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST (2013).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"19487_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transpl."},{"key":"19487_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P., Gray, R. J. & and A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144 (1999).","journal-title":"J. Am. Stat. Assoc."},{"key":"19487_CR33","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U S A. 100, 9440\u20139445. https:\/\/doi.org\/10.1073\/pnas.1530509100 (2003).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"19487_CR34","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397. https:\/\/doi.org\/10.1002\/sim.5958 (2013).","journal-title":"Stat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19487-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19487-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19487-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:19:05Z","timestamp":1760361545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19487-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19487"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19487-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Noriyuki Enomoto has received grants from Boehringer Ingelheim Co., Ltd. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35623"}}